Outlook for the next 5 years in drug innovation

Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2012-06, Vol.11 (6), p.435-436
Hauptverfasser:	Berggren, Roy, Møller, Martin, Moss, Rachel, Poda, Pawel, Smietana, Katarzyna
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/433 631/154/51 66 Antineoplastic Agents - economics Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Biological Products Biomedical and Life Sciences Biomedicine Biotechnology Cancer Research Diffusion of Innovation Drug Discovery - economics Drug Discovery - trends Drug Industry - trends Economics, Pharmaceutical from-the-analysts-couch Humans Industry sales and revenue Investments Medicinal Chemistry Molecular Medicine Pharmaceutical industry Pharmaceutical research Pharmacology/Toxicology Small Molecule Libraries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.
ISSN:	1474-1776 1474-1784
DOI:	10.1038/nrd3744